VIPER AI solutions support care teams by automating the identification of potentially eligible patients at the time of diagnosis and easily matching them to relevant trials
The rolling submission to the U.S. FDA will begin in the fourth quarter of this year
The 462,000 square foot state-of-the-art building targeting LEED Zero certification and is designed to be the most sustainable commercial lab building in Cambridge
According to IQVIA, US sales of Everolimus (Afinitor) tablets were approximately US $ 675 million in the 12 months ending July 2021
The acquisition complements and strengthens Merck’s cardiovascular pipeline
The global wellness market is valued at more than US $ 1.5 trillion, with annual growth of 5-10 per cent
Ryaltris is a fixed dose combination nasal spray that combines an antihistamine (Olopatadine) with a steroid (Mometasone Furoate) for treatment of allergic rhinitis
The CAC solution cleared by the U.S. FDA analyses already existing non-gated CT scans and quantifies the coronary artery calcium in order to identify, stratify, and facilitate treatment pathways for patients with cardiovascular disease
It is the first orally administered therapy for the treatment of two types of ANCA-associated vasculitis approved in Japan
The company does not expect the outcome of this inspection to impact its plans
Subscribe To Our Newsletter & Stay Updated
